137 related articles for article (PubMed ID: 31351317)
1. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
[TBL] [Abstract][Full Text] [Related]
2. Design and development of novel N-(4-aminobenzoyl)- l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitor: An in-silico and in-vitro study.
Adhikari N; Choudhury AAK; Shakya A; Ghosh SK; Patgiri SJ; Singh UP; Bhat HR
J Biochem Mol Toxicol; 2023 Apr; 37(4):e23290. PubMed ID: 36541419
[TBL] [Abstract][Full Text] [Related]
3. Microwave-assisted synthesis of hybrid PABA-1,3,5-triazine derivatives as an antimalarial agent.
Kashyap A; Choudhury AAK; Saha A; Adhikari N; Ghosh SK; Shakya A; Patgiri SJ; Bhattacharyya DR; Singh UP; Bhat HR
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22860. PubMed ID: 34313355
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking and antimalarial evaluation of hybrid
Saha A; Choudhury AAK; Adhikari N; Ghosh SK; Shakya A; Patgiri SJ; Pratap Singh U; Bhat HR
J Biomol Struct Dyn; 2023; 41(24):15520-15534. PubMed ID: 37154740
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
[TBL] [Abstract][Full Text] [Related]
6. Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum.
Yuthavong Y; Vilaivan T; Chareonsethakul N; Kamchonwongpaisan S; Sirawaraporn W; Quarrell R; Lowe G
J Med Chem; 2000 Jul; 43(14):2738-44. PubMed ID: 10893311
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of solution-phase combinatorial library of 4,6-diamino-1,2-dihydro-1,3,5-triazine and identification of new leads against A16V+S108T mutant dihydrofolate reductase of Plasmodium falciparum.
Vilaivan T; Saesaengseerung N; Jarprung D; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Bioorg Med Chem; 2003 Jan; 11(2):217-24. PubMed ID: 12470716
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates.
Lourens AC; Gravestock D; van Zyl RL; Hoppe HC; Kolesnikova N; Taweechai S; Yuthavong Y; Kamchonwongpaisan S; Rousseau AL
Org Biomol Chem; 2016 Aug; 14(33):7899-911. PubMed ID: 27477595
[TBL] [Abstract][Full Text] [Related]
10. In silico screening, synthesis, and antimalarial evaluation of PABA substituted 1,3,5-triazine derivatives as Pf-DHFR inhibitors.
Saha A; Choudhury AAK; Adhikari N; Ghosh SK; Shakya A; Patgiri SJ; Singh UP; Bhat HR
Exp Parasitol; 2023 Jul; 250():108546. PubMed ID: 37196703
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: a novel and potential antifolate lead for Pf-DHFR-TS inhibition.
Gahtori P; Ghosh SK; Parida P; Prakash A; Gogoi K; Bhat HR; Singh UP
Exp Parasitol; 2012 Mar; 130(3):292-9. PubMed ID: 22233734
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS.
Sahu S; Ghosh SK; Kalita J; Dutta M; Bhat HR
Exp Parasitol; 2016 Apr; 163():38-45. PubMed ID: 26821296
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives.
Bhat HR; Ghosh SK; Prakash A; Gogoi K; Singh UP
Lett Appl Microbiol; 2012 May; 54(5):483-6. PubMed ID: 22394198
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
[TBL] [Abstract][Full Text] [Related]
15. Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials.
Jensen NP; Ager AL; Bliss RA; Canfield CJ; Kotecka BM; Rieckmann KH; Terpinski J; Jacobus DP
J Med Chem; 2001 Nov; 44(23):3925-31. PubMed ID: 11689078
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
[TBL] [Abstract][Full Text] [Related]
17. Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Thakkar SS; Thakor P; Ray A; Doshi H; Thakkar VR
Bioorg Med Chem; 2017 Oct; 25(20):5396-5406. PubMed ID: 28789907
[TBL] [Abstract][Full Text] [Related]
18. 3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.
Ewida MA; Ewida HA; Ahmed MS; Allam HA; ElBagary RI; George RF; Georgey HH; El-Subbagh HI
Bioorg Chem; 2021 Oct; 115():105205. PubMed ID: 34329992
[TBL] [Abstract][Full Text] [Related]
19. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
Adane L; Patel DS; Bharatam PV
Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
[TBL] [Abstract][Full Text] [Related]
20. Hybrid PABA-glutamic acid conjugated 1,3,5-triazine derivatives: Design, synthesis, and antimalarial activity screening targeting Plasmodium falciparum dihydro folate reductase enzyme.
Choudhury AAK; Vinayagam S; Adhikari N; Saha A; Ghosh SK; Bhat HR; Patgiri SJ
Chem Biol Drug Des; 2023 Dec; 102(6):1336-1352. PubMed ID: 37783571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
